Search alternatives:
mean decrease » a decrease (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
5 non » _ non (Expand Search), a non (Expand Search), e non (Expand Search)
mean decrease » a decrease (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
5 non » _ non (Expand Search), a non (Expand Search), e non (Expand Search)
-
201
-
202
-
203
-
204
-
205
-
206
-
207
-
208
Decreasing HIV viral loads across subdistricts in KwaZulu-Natal province, South Africa.
Published 2024Subjects: -
209
Shiga toxin expression in O157 following treatment with hGRNL, bNK2A, and pNKL peptides.
Published 2023Subjects: -
210
Projection of testing costs under different cost scenarios for medical supplies and personnel (USD).
Published 2023Subjects: -
211
Summary of resources per type of test and costs for Ag-RDT tests (USD 2020).
Published 2023Subjects: -
212
Unit cost per test type and per health facility for diagnosis of SARS-CoV-2 by Ag-RDT and RT-PCR.
Published 2023Subjects: -
213
-
214
-
215
-
216
-
217
DataSheet5_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx
Published 2021“…</p><p>Material and Methods: Using Markov model and network meta-analysis, we conducted separate cost-effectiveness analyses for cemiplimab, pembrolizumab and atezolizumab among advanced NSCLC patients with PD-L1 of at least 50% from the United States health care sector perspective. …”
-
218
-
219
-
220